Physician profile
Anthony E Niescier
NPI 1720073299
$1,751.41
in general payments reported to CMS, 2019-2025
18 companies · $230 in 2025
The $230 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $814 · 2020: $109 · 2021: $253 · 2023: $115 · 2024: $230 · 2025: $230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $575.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $575.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $231.89 | 2019 | |
| Lilly USA, LLC | $135.62 | 2019-2021 | |
| Acorda Therapeutics, INC | $116.70 | 2019 | |
| Phathom Pharmaceuticals, INC. | $115.00 | 2024 | Voquezna |
| Mallinckrodt Hospital Products INC. | $115.00 | 2023 | Acthar |
| Novo Nordisk INC | $115.00 | 2025 | Ozempic |
| Biocryst US Sales Co., LLC | $115.00 | 2024 | Orladeyo |
| Amgen INC. | $115.00 | 2025 | Krystexxa |
| Valeritas, INC. | $114.31 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $112.83 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $103.74 | 2021 | |
| Sanofi-Aventis U.S. LLC | $103.74 | 2019 | |
| Janssen Pharmaceuticals, INC | $100.72 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $83.30 | 2019 | |
| Astellas Pharma US INC | $21.73 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $20.67 | 2020 | |
| Sunovion Pharmaceuticals INC. | $17.93 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Niescier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.